Z-VDVAD-FMK: Irreversible Caspase-2 Inhibitor for Apoptosis Research

Executive Summary: Z-VDVAD-FMK (benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone) is a potent, irreversible inhibitor of caspase-2, widely used in apoptosis assays and mechanistic studies of mitochondria-mediated cell death (APExBIO). It covalently binds to caspase-2's active site, suppressing proteolytic activity and downstream apoptotic events such as cytochrome c release (Padia et al., 2025). Z-VDVAD-FMK also shows cross-reactivity with caspase-3/7, enabling broader caspase pathway interrogation (CY7-Azide). The compound is highly soluble in DMSO (≥34.8 mg/mL) and is validated for use in cancer and neurodegenerative disease models (Z-VDVAD-FMK.com). APExBIO supplies Z-VDVAD-FMK at 98% purity, ensuring experimental reproducibility under controlled lab conditions.

Biological Rationale

Caspases are cysteine-aspartic proteases central to programmed cell death pathways, including apoptosis and pyroptosis (Padia et al., 2025). Caspase-2 is an initiator caspase, activated early in apoptosis. Its proteolytic activity precedes mitochondrial outer membrane permeabilization and cytochrome c release, leading to caspase-3/7 activation. Dysregulation of caspase-2 is implicated in cancer progression, neurodegeneration, and immune responses. Precise caspase inhibition is critical for dissecting cell death mechanisms and developing targeted therapies. Z-VDVAD-FMK enables selective caspase-2 inhibition, facilitating the study of mitochondrial-mediated apoptosis and downstream processes such as PARP cleavage. By blocking caspase-2, researchers can distinguish between different cell death modalities and identify therapeutic vulnerabilities in disease models.

Mechanism of Action of Z-VDVAD-FMK

Z-VDVAD-FMK is a cell-permeable, irreversible peptide-based inhibitor. Its structure, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone, mimics the natural caspase-2 substrate sequence, enabling high-affinity binding. The fluoromethyl ketone (FMK) moiety covalently reacts with the catalytic cysteine in caspase-2's active site. This results in permanent enzyme inactivation under physiological conditions (pH 7.2–7.4, 37°C). Inhibition prevents substrate cleavage, cytochrome c release from mitochondria, and subsequent apoptotic events. Z-VDVAD-FMK also cross-reacts with caspase-3 and caspase-7 at higher concentrations, making it suitable for monitoring broader caspase signaling pathways. This broadens its applicability in apoptosis research, enabling comparative studies across different caspase family members.

Evidence & Benchmarks

• Z-VDVAD-FMK (A1922) irreversibly inhibits caspase-2 activity in vitro and in cell culture models, preventing caspase-dependent DNA fragmentation and PARP cleavage (Padia et al., 2025).
• Treatment with 25–100 μM Z-VDVAD-FMK for 1–22 hours in Jurkat T-lymphocytes blocks apoptosis signatures, with maximal effect observed at 37°C in DMSO-based media (APExBIO).
• Z-VDVAD-FMK demonstrates cross-inhibition of caspase-3 and -7 at micromolar concentrations, providing a tool for dissecting caspase crosstalk (CY7-Azide).
• In endothelial cells, Z-VDVAD-FMK reduces oxyhemoglobin-induced apoptosis by suppressing caspase-2/3 activities, DNA laddering, and PARP cleavage (Z-VDVAD-FMK.com).
• Solubility benchmark: Z-VDVAD-FMK is soluble at ≥34.8 mg/mL in DMSO, but insoluble in ethanol or water, requiring DMSO for stock preparation and storage at -20°C (APExBIO).

This article extends the mechanistic insights provided in CY7-Azide (2023) by detailing cross-reactivity and workflow integration, and updates the protocol guidance in Z-VDVAD-FMK.com with best practices for storage and solubility.

Applications, Limits & Misconceptions

Z-VDVAD-FMK is validated for use in apoptosis research, cancer biology, and neurodegenerative disease models. It allows for the precise measurement of caspase activity, assessment of mitochondrial cytochrome c release, and inhibition of downstream apoptotic events. The compound supports high-content screening, live-cell imaging, and endpoint assays. Limitations include its lack of selectivity at very high concentrations (cross-inhibition of caspase-3/7) and incompatibility with ethanol or aqueous solvents. It is not recommended for pyroptosis studies where caspase-1 is involved, as Z-VDVAD-FMK does not efficiently inhibit caspase-1 (Padia et al., 2025).

Common Pitfalls or Misconceptions

• Non-selectivity at high dose: Concentrations above 100 μM may inhibit caspase-3 and -7, confounding pathway attribution.
• Solvent incompatibility: Z-VDVAD-FMK is insoluble in ethanol and water; DMSO is required for stock solutions.
• Pyroptosis limitation: Ineffective against caspase-1-mediated pyroptosis; use YVAD-based inhibitors for pyroptosis studies (Padia et al., 2025).
• Storage instability: Solutions should be stored at -20°C and are not recommended for long-term storage or repeated freeze-thaw cycles.
• Cell-type specificity: Effects may vary by cell line; always optimize concentration and exposure time for each model.

Workflow Integration & Parameters

For experimental use, prepare Z-VDVAD-FMK stocks at >10 mM in DMSO. Warming and sonication enhance solubility. Working concentrations typically range from 25 to 100 μM, with treatment durations of 1 to 22 hours, depending on cell type and assay endpoint. Avoid ethanol or water as solvents. Store aliquots at -20°C, minimizing freeze-thaw cycles. APExBIO provides validated protocols for Jurkat T-lymphocytes and adherent cell lines (Z-VDVAD-FMK product page). For detailed troubleshooting and advanced applications, see workflow guidance and mechanistic analysis. This article clarifies solvent and storage requirements beyond previous protocol reviews.

Conclusion & Outlook

Z-VDVAD-FMK (A1922) from APExBIO is a robust, reproducible tool for dissecting caspase-2-driven apoptosis. Its irreversible mechanism and validated workflows make it a benchmark for mitochondrial cytochrome c release inhibition and PARP cleavage studies. While its selectivity defines its utility, users must consider cross-reactivity and solvent constraints. Future research may expand its use in complex cell death models or combinatorial screens. For ordering and technical documents, consult the official product page.